Sensitivity of EGFR/HER-2 Positive Cells Isolated from Ascitic Fluid of Advanced Ovarian Cancer Patients to EGFR/HER-2 Inhibitors

Chitcholtan, K; Harker, D; Simcock, B; Sykes, P

Chitcholtan, K (corresponding author), Univ Otago, Gynaecol Canc Res Grp, Dept Obstet & Gynaecol, Christchurch 8140, New Zealand.

APPLIED SCIENCES-BASEL, 2020; 10 (7):

Abstract

Background: advanced ovarian cancer often presents with ascites. These ascites contain small clusters of cancer cells, which may contribute greatly to......

Full Text Link